Bioscience

Primavera Essentials introduces Neuro-Eze

Primavera Essentials introduces Neuro-Eze

FORT COLLINS -- Primavera Essentials, Inc. announced the launch of Neuro-Eze, a highly specialized topical gel that may help lessen the pain and numbness that neuropathy patients experience in... Read More

Friday April 30, 2021 0 comments Tags: Fort Collins, Primavera Essentials, Neuro-Eze, Preston Wilson, Barry Moore

Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19

Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19

WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More

Thursday April 29, 2021 0 comments Tags: Westminster, Reven Holdings, COVID-19, Fatih Uckun, Peter Lange, Michael Volk, Brian Denomme

KromaTiD receives $2M of growth investment from BroadOak Capital Partners

KromaTiD receives $2M of growth investment from BroadOak Capital Partners

LONGMONT -- KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market... Read More

Thursday April 29, 2021 0 comments Tags: Longmont, KromaTid, BroadOak Capital Partners, Christopher Tompkins

Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%

Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a... Read More

Wednesday April 28, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, Michael Macaluso

CereHealth granted patent for medical imaging quantification

CereHealth granted patent for medical imaging quantification

DENVER -- CereHealth Corporation announced it has been granted a third patent on its novel systems and methodologies used in its FDA-cleared CereMetrix medical imaging and data analytics software. ... Read More

Friday April 23, 2021 0 comments Tags: Denver, CereHealth, John Kelley

Research shows Ampion mimics anti-inflammatory effects of steroids but without adverse effects

Research shows Ampion mimics anti-inflammatory effects of steroids but without adverse effects

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced findings of pre-clinical research demonstrating Ampio's lead drug candidate, Ampion, provides some of the same anti-inflammatory... Read More

Tuesday April 20, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Michael Macaluso

VieCure announces $25M Series A investment led by Northpond Ventures to improve oncology care, scale A.I. and patient-focused technologies

VieCure announces $25M Series A investment led by Northpond Ventures to improve oncology care, scale A.I. and patient-focused technologies

DENVER -- VieCure , Inc . today announced the closing of a $25 million Series A growth equity investment, led by Northpond Ventures . An undisclosed investor is also contributing to the... Read More

Tuesday April 20, 2021 0 comments Tags: Denver, Viecure, Gerry Hogue

TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors

TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors

DENVER -- The University of Texas MD Anderson Cancer Center and Denver-based TriSalus Life Sciences announced a strategic research collaboration to evaluate the treatment of tumors of the... Read More

Thursday April 15, 2021 0 comments Tags: Denver, TriSalus Life Sciences, MD Anderson Cancer Center, Steven Katz